This Article Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Koistinen, H. A. Articles by Ebeling, P. Search for Related Content PubMed PubMed Citation Articles by Koistinen, H. A. Articles by Ebeling, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Related Collections Obesity Gene expression Physiological and pathological control of gene expression Type 2 diabetes Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1034.)
© 2001 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Plasma Acylation Stimulating Protein Concentration and Subcutaneous Adipose Tissue C3 mRNA Expression in Nondiabetic and Type 2 Diabetic Men

Heikki A. Koistinen; Hubert Vidal; Sirkka-Liisa Karonen; Eric Dusserre; Paulette Vallier; Veikko A. Koivisto; Pertti Ebeling

From the Department of Medicine (H.A.K., V.A.K., P.E.), Division of Geriatrics, and the Department of Clinical Chemistry (S.-L.K.), Helsinki University Central Hospital, Helsinki, Finland, and INSERM U449 (H.V., E.D., P.V.), Faculté de Médecine R.T.H. Laennec, Lyon, France. V.A.K. is currently at Eli Lilly Research Laboratories, Hamburg, Germany.

Correspondence to Dr Heikki Koistinen, Karolinska Institutet, Integrativ fysiologi, von Eulers väg 4, 2 TR, 17 177 Stockholm, Sweden. E-mail heikki_koistinen{at}yahoo.com

Abstract—We studied the effect of an oral fat load on plasma acylation stimulating protein (ASP) concentrations in 9 lean healthy (age 59±2 years, body mass index [BMI] 23.2±0.4 kg/m²; both mean±SEM), 9 obese nondiabetic (58±2 years, BMI 29.4±0.5 kg/m²), and 12 type 2 diabetic (60±2 years, BMI 29.6±1.0 kg/m²) men. Because ASP is a cleavage product of complement protein C3 (C3adesArg) and its secretion is regulated by insulin, we also examined the subcutaneous adipose tissue expression of C3 mRNA before and after a 240-minute euglycemic hyperinsulinemic clamp in a subgroup of these men. Plasma ASP concentration and adipose tissue C3 mRNA expression were higher in the obese groups than in the lean men. Plasma ASP concentration did not change significantly after the fat load. Fasting plasma ASP concentration and C3 mRNA expression were correlated negatively with insulin sensitivity and positively with the magnitude of postprandial lipemia in nondiabetic but not in type 2 diabetic men. The expression of C3 mRNA was not regulated by insulin. These data suggest that ASP is associated with whole-body glucose and lipid metabolism in nondiabetic individuals, whereas metabolic disturbances in diabetes may overcome the regulatory role of ASP in lipid and glucose metabolism.

Key Words: acylation stimulating protein (ASP) • insulin resistance • obesity • postprandial lipemia • RT competitive PCR